KVUE Stock Today (Nov. 22, 2025): Kenvue Rises as Kimberly‑Clark Deal, Dividend and Tylenol Ruling Shape Outlook
Published: November 22, 2025 — Information only, not investment advice. KVUE stock price today: trading below deal value but off the lows Kenvue Inc. (NYSE: KVUE) — the consumer health company behind Tylenol, Band‑Aid, Neutrogena and Listerine — is back in focus this weekend after another strong session on Friday. As of the most recent quote in late Friday trading (00:15 UTC on Saturday, November 22), KVUE last changed hands around $16.64, up roughly 3% on the day, with heavy volume of about 47 million shares. That move comes on top of a roughly 17% jump earlier this month when